Literature DB >> 1849626

From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification.

R J Kurman1, G D Malkasian, A Sedlis, D Solomon.   

Abstract

The Bethesda System for reporting cervical/vaginal diagnoses was introduced to replace the numerical Papanicolaou class designations, thereby facilitating precise communication between cytopathologist and clinician. The terminology for squamous epithelial lesions includes the following categories: 1) atypical squamous cells of undetermined significance; 2) squamous intraepithelial lesion (SIL), which encompasses the spectrum of squamous cell carcinoma precursors, divided into low-grade SIL (human papillomavirus [HPV]-associated cellular changes, mild dysplasia, and cervical intraepithelial neoplasia [CIN] I) and high-grade SIL (moderate dysplasia, severe dysplasia, and carcinoma in situ and CIN II and III); and 3) squamous cell carcinoma. The rationale for including HPV-related changes (koilocytosis) with CIN I within low-grade SIL is based on the morphologic, behavioral, and virologic similarity of these two lesions, which precludes their separation in a consistent and reliable fashion. For the same reasons, CIN II and III lesions have been combined within the category of high-grade SIL. The term "atypical squamous cells of undetermined significance" is used for cytologic findings that do not fulfill the criteria for defined benign reactive changes or SIL. Therefore, this term is more restricted in usage as compared with the wide range of interpretations previously ascribed to "atypia" or "inflammatory atypia."

Entities:  

Mesh:

Year:  1991        PMID: 1849626

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Evaluation of a new DNA test for detection of carcinogenic human papillomavirus.

Authors:  Philip E Castle; Erin C Gutierrez; Sharon V Leitch; Courtney E Maus; Ray A McMillian; William A Nussbaumer; Laurence M Vaughan; Cosette M Wheeler; Patti E Gravitt; Mark Schiffman
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

2.  Adequacy of urine cytology specimens: an assessment of collection techniques.

Authors:  Andrew F Hundley; Susan Maygarden; Jennifer M Wu; Anthony G Visco; AnnaMarie Connolly
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-01-05

Review 3.  How will HPV vaccines affect cervical cancer?

Authors:  Richard Roden; T-C Wu
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

4.  Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.

Authors:  Philip E Castle; Mark Schiffman; Cosette M Wheeler; Nicolas Wentzensen; Patti E Gravitt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07       Impact factor: 4.254

5.  Inverted (hobnail) high-grade prostatic intraepithelial neoplasia and invasive inverted pattern.

Authors:  Meltem Öznur; Sevim Baykal Koca; Pelin Yildiz; Burak Bahadir; Kemal Behzatoğlu
Journal:  Oncol Lett       Date:  2015-08-10       Impact factor: 2.967

6.  Age-specific patterns of unsatisfactory results for conventional Pap smears and liquid-based cytology: data from two randomised clinical trials.

Authors:  P E Castle; J Bulten; M Confortini; P Klinkhamer; A Pellegrini; A G Siebers; G Ronco; M Arbyn
Journal:  BJOG       Date:  2010-08       Impact factor: 6.531

7.  National Breast and Cervical Cancer Early Detection Program data validation project.

Authors:  Christie R Eheman; Steven Leadbetter; Vicki B Benard; A Blythe Ryerson; Janet E Royalty; Donald Blackman; Lori A Pollack; Paula Willey Adams; Fran Babcock
Journal:  Cancer       Date:  2014-08-15       Impact factor: 6.860

8.  Impact of improved classification on the association of human papillomavirus with cervical precancer.

Authors:  Philip E Castle; Mark Schiffman; Cosette M Wheeler; Nicolas Wentzensen; Patti E Gravitt
Journal:  Am J Epidemiol       Date:  2009-12-10       Impact factor: 4.897

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.